Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial.
Aika MiyaAkinobu NakamuraHideaki MiyoshiKyu Yong ChoSo NagaiYoshio KuriharaShin AokiMasataka TaguriYasuo TerauchiTatsuya AtsumiPublished in: Journal of diabetes investigation (2017)
Switching from MDI to combination therapy with LIX and basal insulin improved satisfaction levels while maintaining glycemic control in Japanese patients with type 2 diabetes.